Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC

Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC–MS metabolomics

Published:2016-07 Issue:7 Volume:12 Page:
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Cowan Elaine,Kumar Praveen,Burch Kerry J.,Grieve David J.,Green Brian D.,Graham Stewart F.

Funder

Department of Education and Learning, Northern Ireland

Translational Research Group, Northern Ireland

Queen's University Belfast

British Heart Foundation

Beaumont Health System

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11306-016-1063-0.pdf

Reference66 articles.

1. Agnew, A., Calderwood, D., Chevallier, O. P., Greer, B., Grieve, D. J., & Green, B. D. (2011). Chronic treatment with a stable obestatin analog significantly alters plasma triglyceride levels but fails to influence food intake; fluid intake; body weight; or body composition in rats. Peptides, 32(4), 755–762. doi: 10.1016/j.peptides.2010.12.005 .

2. Agnew, A. J., Robinson, E., McVicar, C. M., Harvey, A. P., Ali, I. H., Lindsay, J. E., et al. (2012). The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling. British Journal of Pharmacology, 166(1), 327–338. doi: 10.1111/j.1476-5381.2011.01761.x .

3. Aiyar, N., Disa, J., Ao, Z., Ju, H., Nerurkar, S., Willette, R. N., et al. (2007). Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Molecular and Cellular Biochemistry, 295(1–2), 113–120. doi: 10.1007/s11010-006-9280-x .

4. Anderson, S. G., Dunn, W. B., Banerjee, M., Brown, M., Broadhurst, D. I., Goodacre, R., et al. (2014). Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLoS ONE, 9(9), e103217. doi: 10.1371/journal.pone.0103217 .

5. Ataka, K., Inui, A., Asakawa, A., Kato, I., & Fujimiya, M. (2008). Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. American Journal of Physiology-Gastrointestinal and Liver Physiology, 294(5), G1210–G1218. doi: 10.1152/ajpgi.00549.2007 .

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-targeted LC–MS/MS metabolomic profiling of human plasma uncovers a novel Mediterranean diet biomarker panel;Metabolomics;2023-12-08

2. Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes;Reference Module in Biomedical Sciences;2021

3. Sensor of molecular imbalance in metabolic disorder: Determination of molecular behavior wired in disease utilizing metabolomics;Journal of Addiction Medicine and Therapeutic Science;2020-07-20

4. Dietary effects on pelage emissivity in mammals: Implications for infrared thermography;Journal of Thermal Biology;2020-02

5. Biochemical properties and biological actions of obestatin and its relevence in type 2 diabetes;Peptides;2018-02